Pharma-Bio Serv (PBSV) Total Current Liabilities (2010 - 2026)

Pharma-Bio Serv's Total Current Liabilities history runs 16 years deep, the most recent figure standing at $1.0 million for Q2 2026.

• Quarterly Total Current Liabilities fell 41.29% year-over-year to $1.0 million in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $1.0 million (down 41.29% YoY) and the FY2025 annual result came in at $1.7 million, down 7.86% from the prior year.
• Total Current Liabilities was $1.0 million for Q2 2026 at Pharma-Bio Serv, down from $3.3 million in the prior quarter.
• Across five years, Total Current Liabilities topped out at $3.7 million in Q1 2024 and bottomed at $1.0 million in Q2 2026.
• A 5-year average of $2.2 million and a median of $2.2 million in 2022 frame the typical range for Total Current Liabilities.
• Annual changes were most pronounced in 2022 — Total Current Liabilities plunged 58.05% — and 2024, when it surged 87.53%.
• Pharma-Bio Serv's Total Current Liabilities stood at $2.1 million in 2022, then rose by 2.18% to $2.2 million in 2023, then slipped by 12.37% to $1.9 million in 2024, then slipped by 7.86% to $1.7 million in 2025, then plunged by 39.89% to $1.0 million in 2026.
• Business Quant data shows PBSV's Total Current Liabilities at $1.0 million in Q2 2026, $3.3 million in Q1 2026, and $1.7 million in Q4 2025.